234 related articles for article (PubMed ID: 33521701)
1. Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
Dijkman K; Aguilo N; Boot C; Hofman SO; Sombroek CC; Vervenne RAW; Kocken CHM; Marinova D; Thole J; Rodríguez E; Vierboom MPM; Haanstra KG; Puentes E; Martin C; Verreck FAW
Cell Rep Med; 2021 Jan; 2(1):100187. PubMed ID: 33521701
[TBL] [Abstract][Full Text] [Related]
2. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination.
Vierboom MPM; Dijkman K; Sombroek CC; Hofman SO; Boot C; Vervenne RAW; Haanstra KG; van der Sande M; van Emst L; Domínguez-Andrés J; Moorlag SJCFM; Kocken CHM; Thole J; Rodríguez E; Puentes E; Martens JHA; van Crevel R; Netea MG; Aguilo N; Martin C; Verreck FAW
Cell Rep Med; 2021 Jan; 2(1):100185. PubMed ID: 33521699
[TBL] [Abstract][Full Text] [Related]
3. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
[TBL] [Abstract][Full Text] [Related]
5. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
[TBL] [Abstract][Full Text] [Related]
6. Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination.
Guerra-Maupome M; McGill JL
Sci Rep; 2019 Nov; 9(1):15996. PubMed ID: 31690788
[TBL] [Abstract][Full Text] [Related]
7. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.
Pitt JM; Stavropoulos E; Redford PS; Beebe AM; Bancroft GJ; Young DB; O'Garra A
J Immunol; 2012 Oct; 189(8):4079-87. PubMed ID: 22972927
[TBL] [Abstract][Full Text] [Related]
8. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
[TBL] [Abstract][Full Text] [Related]
9. Low-dose
Peralta Alvarez MP; Jones H; Redondo Azema H; Davis C; White AD; Sarfas C; Dennis M; Li S; Wright D; Puentes E; Kimuda S; Belij-Rammerstorfer S; Aguilo N; Martin C; Sharpe S; McShane H; Tanner R
Front Immunol; 2024; 15():1387454. PubMed ID: 38799468
[TBL] [Abstract][Full Text] [Related]
10. Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails.
Verreck FAW; Tchilian EZ; Vervenne RAW; Sombroek CC; Kondova I; Eissen OA; Sommandas V; van der Werff NM; Verschoor E; Braskamp G; Bakker J; Langermans JAM; Heidt PJ; Ottenhoff THM; van Kralingen KW; Thomas AW; Beverley PCL; Kocken CHM
Tuberculosis (Edinb); 2017 May; 104():46-57. PubMed ID: 28454649
[TBL] [Abstract][Full Text] [Related]
11. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.
Gupta T; LaGatta M; Helms S; Pavlicek RL; Owino SO; Sakamoto K; Nagy T; Harvey SB; Papania M; Ledden S; Schultz KT; McCombs C; Quinn FD; Karls RK
Tuberculosis (Edinb); 2018 Dec; 113():179-188. PubMed ID: 30514501
[TBL] [Abstract][Full Text] [Related]
13. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
[TBL] [Abstract][Full Text] [Related]
14. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
[TBL] [Abstract][Full Text] [Related]
15. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
[TBL] [Abstract][Full Text] [Related]
16. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
Horvath CN; Xing Z
Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
[TBL] [Abstract][Full Text] [Related]
17. B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.
Kozakiewicz L; Chen Y; Xu J; Wang Y; Dunussi-Joannopoulos K; Ou Q; Flynn JL; Porcelli SA; Jacobs WR; Chan J
PLoS Pathog; 2013; 9(7):e1003472. PubMed ID: 23853593
[TBL] [Abstract][Full Text] [Related]
18. Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against
Jong RM; Van Dis E; Berry SB; Nguyenla X; Baltodano A; Pastenkos G; Xu C; Fox D; Yosef N; McWhirter SM; Stanley SA
J Immunol; 2022 Jan; 208(2):407-419. PubMed ID: 34965963
[TBL] [Abstract][Full Text] [Related]
19. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.
Darrah PA; Bolton DL; Lackner AA; Kaushal D; Aye PP; Mehra S; Blanchard JL; Didier PJ; Roy CJ; Rao SS; Hokey DA; Scanga CA; Sizemore DR; Sadoff JC; Roederer M; Seder RA
J Immunol; 2014 Aug; 193(4):1799-811. PubMed ID: 25024382
[TBL] [Abstract][Full Text] [Related]
20. New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia.
Tarancón R; Domínguez-Andrés J; Uranga S; Ferreira AV; Groh LA; Domenech M; González-Camacho F; Riksen NP; Aguilo N; Yuste J; Martín C; Netea MG
PLoS Pathog; 2020 Apr; 16(4):e1008404. PubMed ID: 32240273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
